Shah Nimish P
- SEC CIK
- 0001698082
In the past year, 1 open-market sale filing worth $3.69M and no purchases.
Current role at each company
- KRSA Korsana Biosciences, Inc.Directoras of Sep 10, 2026
- APGE Apogee Therapeutics, Inc.Directoras of Sep 3, 2026
- KALV KalVista Pharmaceuticals, Inc.10% Owneras of Mar 27, 2026
- ORKA Oruka Therapeutics, Inc.10% Owneras of Feb 27, 2025
- TCDA Tricida, Inc.10% Owneras of Oct 26, 2022
Show 1 more company
- VTGN Vistagen Therapeutics, Inc.10% Owneras of Jul 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.69M
- 1 filing
- Net
- −$3.69M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Shah Nimish P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KALV KalVista Pharmaceuticals, Inc.
10% Owner15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 (view filing)5:50 PM ET | Mar 25-26 | 2 days | Koh Bong Y and 6 others10% Owner | SSale | −214.6K | $17.20 | −$3.69M | −4.0%5.09M after | 5 lots |
| Apr 11, 2025 (view filing)5:22 PM ET | Apr 9 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +25.0K | $9.42 | +$235.5K | +0.5%5.30M after | |
| Feb 14, 2025 (view filing)7:45 PM ET | Feb 12-13 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +161.7K | $9.27 | +$1.50M | +3.2%5.28M after | 2 lots |
| Feb 11, 2025 (view filing)7:51 PM ET | Feb 7-11 | 4 days | Koh Bong Y and 6 others10% Owner | PPurchase | +104.5K | $9.26 | +$967.1K | +2.1%5.12M after | 3 lots |
| Feb 3, 2025 (view filing)7:42 PM ET | Jan 30-Feb 3 | 4 days | Koh Bong Y and 6 others10% Owner | PPurchase | +70.0K | $8.88 | +$621.6K | +1.4%5.01M after | 3 lots |
| Feb 22, 2024 (view filing)4:15 PM ET | Feb 20 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +655.7K | $15.25 | +$10.0M | –655.7K after | Derivative |
| Feb 8, 2024 (view filing)8:11 PM ET | Feb 6-8 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +86.0K | $14.62 | +$1.26M | +1.8%4.82M after | 3 lots |
| Feb 1, 2024 (view filing)4:38 PM ET | Jan 30 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +88.1K | $14.47 | +$1.27M | +1.9%4.74M after | |
| Jan 29, 2024 (view filing)7:07 PM ET | Jan 25-29 | 4 days | Koh Bong Y and 6 others10% Owner | PPurchase | +91.8K | $14.05 | +$1.29M | +2.0%4.65M after | 3 lots |
| Jan 24, 2024 (view filing)8:24 PM ET | Jan 22-24 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +99.1K | $12.53 | +$1.24M | +2.2%4.56M after | 3 lots |
APGE Apogee Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 (view filing) | Oct 10 | 5 days | Shah Nimish PDirector | PPurchase | +365.9K | $41.00 | +$15.0M | –365.9K after | Derivative |
| Jul 17, 2023 (view filing) | Jul 13 | 4 days | Shah Nimish PDirector | PPurchase | +1.75M | $17.00 | +$29.8M | New position1.75M after |
ORKA Oruka Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 (view filing)6:42 PM ET | Feb 10-14 | 17 daysLate | Koh Bong Y and 6 others10% Owner | PPurchase | +122.9K | $11.45 | +$1.41M | +3.1%4.15M after | 5 lots |
TCDA Tricida, Inc.
10% Owner20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 (view filing)6:32 PM ET | Oct 24-26 | 2 days | VHCP Management II, LLC and 9 others10% Owner | SSale | −6.45M | $0.5427 | −$3.50M | −63.2%3.75M after | 3 lots |
| Oct 20, 2022 (view filing)5:25 PM ET | Oct 18-19 | 2 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +351.9K | $10.68 | +$3.76M | +3.6%10.2M after | 3 lots |
| Oct 17, 2022 (view filing)5:26 PM ET | Oct 13-17 | 4 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +175.0K | $11.68 | +$2.04M | +1.8%9.85M after | 2 lots |
| Oct 11, 2022 (view filing)6:13 PM ET | Oct 7-11 | 4 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +134.2K | $11.91 | +$1.60M | +1.4%9.68M after | 3 lots |
| Oct 6, 2022 (view filing)4:50 PM ET | Oct 4 | 2 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +223.1K | $11.81 | +$2.63M | +2.4%9.54M after | |
| Oct 3, 2022 (view filing)5:49 PM ET | Sep 29-Oct 3 | 4 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +436.9K | $10.75 | +$4.70M | +4.9%9.32M after | 2 lots |
| Sep 28, 2022 (view filing)8:05 PM ET | Sep 26-28 | 2 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +587.2K | $8.90 | +$5.23M | +7.1%8.88M after | 3 lots |
| Sep 7, 2022 (view filing)4:12 PM ET | Sep 2-7 | 5 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +686.7K | $11.53 | +$7.92M | +9.0%8.29M after | 3 lots |
| Sep 1, 2022 (view filing)4:18 PM ET | Aug 30 | 2 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +50.0K | $12.20 | +$610.0K | +0.7%7.61M after | |
| Aug 2, 2022 (view filing)5:32 PM ET | Jul 29 | 4 days | VHCP Management II, LLC and 9 others10% Owner | PPurchase | +18.9K | $9.21 | +$174.1K | +0.3%7.56M after |
VTGN Vistagen Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2022 (view filing)5:33 PM ET | Jul 12 | 2 days | VHCP Management II, LLC and 9 others10% Owner | SSale | −60.0K | $0.89 | −$53.4K | −0.3%20.6M after |